Table 1 Clinicopathological characteristics.
|  | CSD/NCSD n = 41 (%) | Mucosal n = 25 (%) | Acral n = 15 (%) | p value |
|---|---|---|---|---|
Median age (range) | 44 (36–59) | 53 (48–64) | 55 (50–60) | 0.085 |
Gender (%) | Â | Â | Â | 0.315 |
Male | 23 (56.1) | 12 (48.0) | 5 (33.3) | Â |
Female | 18 (43.9) | 13 (52.0) | 10 (66.7) | Â |
Stage (%) | Â | Â | Â | 0.047 |
IA | 1 (2.9) | 0 (0) | 0 (0) | Â |
IIA | 1 (2.9) | 2 (10) | 2 (13.3) | Â |
IIB | 5 (14.7) | 3 (15.0) | 0 (0) | Â |
IIC | 3 (8.8) | 1(5.0) | 5 (33.3) | Â |
IIIA | 0 (0) | 3(15.0) | 0 (0) | Â |
IIIB | 2 (5.9) | 2(10.0) | 0 (0) | Â |
IIIC | 15 (44.1) | 3(15.0) | 5 (33.3) | Â |
IV | 7 (20.6) | 6 (30.0) | 3 (20.0) | Â |
Sample type (%) | Â | Â | Â | 0.584 |
Primary | 35(85.4) | 21 (84.0) | 11 (73.3) | Â |
Metastatic | 6(14.6) | 4 (16.0) | 4 (26.7) | Â |
Ulceration (%) | Â | Â | Â | 0.020 |
0 | 30 (73.2) | 17 (68.0) | 5 (33.3) | Â |
1 | 11 (26.8) | 8 (32.0) | 10 (66.7) | Â |
Congenital nevus (%) | Â | Â | Â | 0.001 |
0 | 26 (63.4) | 25 (100.0) | 14 (93.3) | Â |
1 | 15 (36.6) | 0 (0) | 1 (6.7) | Â |
Trauma (%) | Â | Â | Â | 0.014 |
0 | 34 (82.9) | 24 (96.0) | 9 (60.0) | Â |
1 | 7 (17.1) | 1 (4.0) | 6 (40.0) | Â |
Sun exposure (%) | Â | Â | Â | 0.001 |
0 | 29 (70.7) | 25 (100.0) | 15 (100.0) | Â |
1 | 12 (29.3) | 0 (0) | 0 (0) | Â |
